We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Oxford Nutra Gp | ONG | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 4.00 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 4.00 |
| Top Posts |
|---|
Posted at 19/4/2011 06:34 by wilba ONG signed 7 year licensing deal in Brazil. The good news just keeps coming. |
Posted at 05/4/2011 08:13 by wilba Two trades dissapeared from ONG this am prior to 09:00. A 350k approx sell and a 250k buy. Then the 1 mill buy and two mill buys appeared and the bid dropped to 3.25. There has been some share changes here over the last month between II's and company holders. Something going on here prior to results. Expected near term. |
Posted at 11/2/2011 19:13 by mike111d Wilba, thanks but no thanks. I would rather invest in something with some substance to it, than a pure ramp on the boards. Currently invested at placing prices in a few places, where I anticipate decent near term returns and little hassle whilst holding. So no sorry I am not going to buy ONG to give someone else the chance they are hoping for to get their stake money back out. |
Posted at 11/2/2011 09:37 by pre pennylane2...are you saying that there will be a placing at ong? |
Posted at 11/2/2011 09:21 by excellance 7b,i know what you mean about ONG, but you have to take a longer view, and at the current mkt cap the share price is good value... meanwhile SAR are also a long term share but their share price was silly high, and the placing at 1.5p proved that... SAR have been given a dose of reality, but dont get me wrong i think they will be valued at a multiple of their current sp, but to think it would happen over night is a little short sighted... ONG are good value at up to £10m mkt cap IMHO |
Posted at 11/2/2011 09:05 by 7bore go_baby_go - 11 Feb'11 - 08:12 - 72 of 83 this could do another SAR 10p end of day SAR just announced a possible cure for Cancer and all this company do is make a 2 chewable vitamins and are developing a chewable ibuprofen in which the influential Witney Gazette says they "are aiming to have a licence for early products some time in 2012". it was always going to go up this morning due to the ramping on all the BB's but ONG just sells chewable vitamins at the moment with no chance of a chewable ibuprofen until 2012 minimum. theres going to be a few burnt fingers when people realise they have just bought into a chewable vitamin company. |
Posted at 11/2/2011 08:20 by pennylane2 ong has been in my watchlist and has been accumulating since then. |
Posted at 11/2/2011 07:19 by oakville ONG"MARY Poppins once sang that a spoonful of sugar helps the medicine go down. Now an Oxfordshire biotech firm has set out to prove her right by developing a new form of a common painkiller that tastes a lot sweeter. Researchers at Oxford Nutrascience have been working on ways of making ibuprofen more palatable by cutting out the burning sensation it sends to the throat and replacing it with more pleasant flavours. Now the company, which span out of the chemistry department of Oxford University in 2008, has signed a licensing agreement with Isis Innovation, the university's technology transfer company, to develop and commercialise the technology. As a result, the first ibuprofen "chews" and liquid could be on the market as early as next year. Marcelo Bravo, executive chairman and chief technology officer at Oxford Nutrascience, said: "Ibuprofen has been around a long time but delivers a burning sensation to the throat. "Using this technology we can deliver chewable and liquid forms of the drug using much higher doses suitable for some treatment needs and now we are working out how to take this to an industrial level." The potential of the breakthrough is huge. Mr Bravo said the current market for ibuprofen, originally invented by chemists at Boots, was £1.5bn a year. He added that manufacturers of ibuprofen had been "very enthusiastic" about the development which could lead to different flavours being used in different markets depending on local tastes. "The response has been outstanding. We are talking to the top five people in the world right now - it is a question of execution. "The regulatory experts are still quite complex but we are aiming to have a licence for early products some time in 2012." Oxford Nutrascience based at the Begbroke Innovation Centre, Yarnton, has a staff of four but uses a wide range of research partners to develop its technology. As well as ibuprofen, the company is developing new its taste-masking technology for a range of products, including fish oil and calcium supplements." |
Posted at 11/2/2011 07:14 by oakville Good morning to anybody bothered to trade ONG.. |
Posted at 10/2/2011 17:46 by 22hoper Wilba, when you consider that most companies at this share price have around 2 billion shares in public issue. Then compare ong with their fantastic product and a tiny amount of shares in public issue. Then just a incy bit of volume and it will zoooooom. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
